Philip Morris


Vaccine developer Medicago raises $11M from Philip Morris investment

Biotechnology company Medicago (TSX:MDG), whose technology makes vaccines from tobacco leaves, now has an additional $11.1 million from an investor who knows a thing or two about the golden leaf: Philip Morris (NYSE:PM). Medicago shareholders approved the investment, the second tranche of a $22.5 million private placement with the tobacco giant. Philip Morris is acquiring […]